Surgery CME

Credits: 1.50 CME / MOC / CNE
Medical Learning Institute, Inc.
The Expanding Role of Immunotherapy in Locally Advanced and Earlier Stages of Lung Cancer: Rationale, Current Evidence, Key Trials, and Implications for Thoracic Surgeons
Jessica Donington, MD
17 June, 2019
Credits: 1.25 CME / MOC / CNE
Medical Learning Institute, Inc.
On the Cusp of the Era of Immuno-Oncology in Triple-Negative Breast Cancer: Rational Strategies to Make the Most of Immunotherapies and Other Effective Treatment Modalities Throughout the Disease Continuum
Elizabeth A. Mittendorf, MD, PhD
3 June, 2019
Credits: 1.00 CME
Medical Learning Institute, Inc.
Progress and Promise With Immunotherapy in Resectable Melanoma: Exploring New Evidence and Practical Issues With Checkpoint Inhibitors as Adjuvant Therapy
Jason J. Luke, MD, FACP / Jennifer Wargo, MD, MMSc
25 April, 2019
Credits: 1.00 CME
The Medical College of Wisconsin
Innovative Therapeutic Concepts for ASCT-Eligible Patients With Myeloma: Advancing Toward More Effective Care Across Treatment Settings
Sagar Lonial, MD, FACP
10 April, 2019
Credits: 1.00 CME
The Medical College of Wisconsin
Attacking the Clinical Problem of VOD/SOS in HCT Recipients: Insights on Pathophysiology, Diagnosis, and Treatment
Mitchell Cairo, MD
3 April, 2019
Credits: 1.00 CME
The Medical College of Wisconsin
Harnessing Recent Advances in CAR-T Cell Therapy for Leukemia and Lymphoma in the Era of Stem Cell Transplantation
Tanya Siddiqi, MD / Shannon L. Maude, MD, PhD
2 April, 2019
Credits: 1.00 CME
The Medical College of Wisconsin
Integrating Innovative Therapeutics With Allogeneic HCT in AML: Insights and Evidence From Induction to Maintenance
Alexander Perl, MD / James M. Foran, MD, FRCPC
29 March, 2019
Credits: 1.00 CME
The Medical College of Wisconsin
Innovative Therapies in Post-Transplant GVHD: Personal Insights From the Patient CaseBook
Madan Jagasia, MBBS, MS, MMHC
28 March, 2019
Credits: 1.00 CME
The Medical College of Wisconsin
Managing CMV in the New Era of Antiviral Therapy: Practical Considerations in the HCT Setting
Roy Chemaly, MD, MPH, FIDSA, FACP
26 March, 2019
Credits: 1.00 CME / MOC / CE
Medical Learning Institute, Inc.
The Evolving Role of Immunotherapy as a Component of Multimodal Therapy in Earlier Stages of Lung Cancer: Rationale, Current Evidence, Key Trials, and Implications for Multidisciplinary Care
Naiyer Rizvi, MD
14 December, 2018
Credits: 1.50 CME
Penn State College of Medicine
Innovative Therapy in B-Cell Malignancies: An Expert Tumor Board on Novel Agent Classes in CLL, FL, and MCL
Nathan Fowler, MD
9 October, 2018